Liraglutide Limited Experience in Bahrain

Abeer Al Saweer

doi:10.12816/0008114

Article Details

Liraglutide Limited Experience in Bahrain

Authors:

Abeer Al Saweer

Publisher:

King Hamad University Hospital

Main Topics:

Medicine

Journal:

Bahrain Medical Bulletin 2014 Vol.36 Issue 3, pp.178-180

Document Type:

Article

Publication Date:

9/2014

Document Language:

English

Document ID (Org No.):

56115

Frequency:

Quarterly

pISSN:

10128298

DOI:

10.12816/0008114

Descriptors:

Abstract:

 Background: Liraglutide is a Glucagon like peptide-1 (GLP-1) agonist which has been approvedin the treatment of type 2 diabetes. This drug has gained popularity because of its multipleadvantages. It controls blood glucose, reduces weight, regulates blood pressure and retains betacell mass in the pancreas of diabetic patients.The primary objective of this small intervention is to assess and compare the efficacy (changein HbA1c) after 26 weeks of adding Liraglutide to the pre-trial in subjects with inadequatelycontrolled type 2 diabetes.Design: A Prospective Clinical Trial.Setting: A’Ali Health Center, Bahrain.Method: Four patients who were residents of A’Ali, BMI ≥35 and uncontrolled diabetic onmedication (HbA1c >7%) were recruited for twenty-six weeks clinical trial to receive Liraglutide.The small cohort was followed up, and glycemic control and BMI were assessed pre and posttrial.Result: Obvious reduction in glycemic control and weight were noticed at the end of the 26weeks.Conclusion: In this small trial, Liraglutide is effective in improving glycemic control and reducingweight

Article Details

Liraglutide Limited Experience in Bahrain

Authors:

Abeer Al Saweer

Publisher:

King Hamad University Hospital

Main Topics:

Medicine

Journal:

Bahrain Medical Bulletin 2014 Vol.36 Issue 3, pp.178-180

Document Type:

Article

Publication Date:

9/2014

Document Language:

English

Document ID (Org No.):

56115

Frequency:

Quarterly

pISSN:

10128298

DOI:

10.12816/0008114

Descriptors:

DIABETES

DRUGS

GLUCAGON

THERAPY

PATIENTS

BAHRAIN

Issues

Article Details

Liraglutide Limited Experience in Bahrain

Authors: Abeer Al Saweer

Publisher: King Hamad University Hospital

Main Topics: Medicine

Journal: Bahrain Medical Bulletin 2014 Vol.36 Issue 3, pp.178-180

Document Type: Article

Publication Date: 9/2014

Document Language: English

Document ID (Org No.): 56115

Frequency: Quarterly

pISSN: 10128298

DOI: 10.12816/0008114

Descriptors:

DIABETES

DRUGS

GLUCAGON

THERAPY

PATIENTS

BAHRAIN

Issues

Authors:

Abeer Al Saweer

Publisher:

King Hamad University Hospital

Main Topics:

Medicine

Journal:

Bahrain Medical Bulletin 2014 Vol.36 Issue 3, pp.178-180

Document Type:

Article

Publication Date:

9/2014

Document Language:

English

Document ID (Org No.):

56115

Frequency:

Quarterly

pISSN:

10128298

DOI:

10.12816/0008114